3-4

Zydus Cadila is an innovative global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare products. The groups operations range from API to formulations, animal health products and cosmeceuticals. Headquartered in the city of Ahmedabad in India, the group has global operations in four continents spread across USA, Europe, Japan, Brazil, South Africa and 25 other emerging markets.

Piramal Enterprises Limited is the flagship company of the Piramal Group.  Starting from the mid-1980s, PEL has shifted its focus from the textiles industry, and established its entrepreneurial credentials in Pharma, Information Management, and Financial Services. It has grown organically and inorganically and often made contrarian business calls.  When Indian pharmaceutical industry was focused on international generics, we invested in domestic formulation businesses.

Post : Sr. Research Associate/ Research Scientist

[adsense:336x280:8701650588]

Aurobindo Pharma Ltd., is a Leading Pharmaceutical company having 23 plants worldwide with regulatory approvals from USFDA, UK, MHRA etc. with a turnover of more than $2.5 billion dollars. Aurobindo Pharma has identified international operations, catering to over 100 countries, as a major engine of growth and expanding global network of marketing and manufacturing operations across countries like China, Brazil, Japan, Netherlands, South Africa, Thailand, UK, USA, Russia, Netherlands and many more which will further expand its international reach.

Ipca has been partnering healthcare globally in over 110 countries and in markets as diverse as Africa, Asia, Australia, Europe and the US. Ipca is a fully-integrated Indian pharmaceutical company manufacturing over 350 formulations and 80 APIs for various therapeutic segments. We are one of the world's largest manufacturers and suppliers of over a dozen APIs. These are produced right from the basic stage at manufacturing facilities endorsed by the world's most discerning drug regulatory authorities like US-FDA, UK-MHRA, EDQM-Europe, WHO-Geneva and many more. Ipca is a therapy leader in India for anti-malarials with a market-share of over 34% with a fast expanding presence in the international market as well.

CACTUS is recognized for its expertise in providing publications and medcom services to global client teams from the US, UK, Germany, and Japan, among other geographies. CACTUS acts as a trusted advisor and works as an extension of its client teams by not only delivering high-quality work consistently, but also providing strategic guidance for their medical communications needs. Clients value the flexible, innovative solutions provided by CACTUS that allows them to manage their budgets wisely and do more with less.

Post : Assistant Manager - Inside Sales (Medical Communications)

The genesis of the ISHITA group in 1972 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal, who set up a reactive dye manufacturing unit in Ahmedabad. Buoyed by the growth of its first Venture, the group made its maiden foray in the pharma sector in 1981 by setting up a small Bulk drugs plant at Surendranagar in the state of Gujarat, to cater to the need of Pharma industry for Quality Products. The Bulk Drugs Industry at that point of time was highly dependent on costly imports and the growth was not easily achievable. But ‘ISHITA’ continued to achieve excellence in Quality of its products using innovative technology, and cost effective processes developed by in house R&D.Manufacturer of various Active Pharma Ingredients (bulk actives and their salts), drug intermediates, excipients and fine chemicals.

Post : QC Chemist

GVK Biosciences is leading Informatics Services provider with wide range of Products and Services across the R&D value chain. Considered a market leader in the development of MANUALLY curated databases, GVK BIOs databases on SAR, PK/Tox and other areas are widely used in the industry and their utility have been well documented in the scientific literature.

Post : Research Associate / Senior Research Associate (LCMS)

Otsuka Pharmaceutical India Private Limited (OPI) is a Joint Venture between Otsuka Pharmaceutical Factory, Inc., Japan and Mitsui & Co. Ltd., Japan, India, for Infusion Business in India and Emerging Markets.

Mankind Pharma is one of India's leading healthcare companies. Today, we have more than 14,000 employees and total turnover of INR 4500 Crore. Today, Mankind operates in 22 overseas countries across Asia, Africa, South-East Asia and Gulf countries. The group has state-of-the-art manufacturing facility located at Paonta Sahib and Sikkim for manufacturing Solid Orals, Parenteral, Ophthalmic preparations and API manufacturing facility at Behror, Rajasthan. We have world class, state of the art R&D centre at Manaser, Delhi NCR. We are looking for young and dynamic personnel from Pharma background with proven track records, who have exposure to regulated environment (USFDA, TGA, EDQM, MHRA, etc) for Sterile Injectable Formulation Unit at Mankind Pharma